Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Biernat

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Cancers|November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha SurveyChiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Open Forum Infectious Diseases|March 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA RegistryJon Salmanton-García, Francesco Marchesi, Erica Mackenzie, et al.
Eclinicalmedicine|April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registryJon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Blood|September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA surveyLivio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
American Journal of Hematology|December 23, 2024
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA ReportJon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
American Journal of Hematology|December 24, 2025
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA RegistryJon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Haematologica|April 4, 2024
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registryTommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, et al.
Journal of Hematology & Oncology|October 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cancers|November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha SurveyChiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Open Forum Infectious Diseases|March 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA RegistryJon Salmanton-García, Francesco Marchesi, Erica Mackenzie, et al.
Eclinicalmedicine|April 12, 2023
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registryJon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, et al.
Blood|September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA surveyLivio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
American Journal of Hematology|December 23, 2024
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA ReportJon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
American Journal of Hematology|December 24, 2025
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA RegistryJon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Haematologica|April 4, 2024
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registryTommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, et al.
Journal of Hematology & Oncology|October 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Pageof 6